|
| 37495639 | An intranasal vaccine comprising SARS-CoV-2 spike receptor-binding domain protein entrapped in mannose-conjugated chitosan nanoparticle provides protection in hamsters. | | 2023 |
| 36043937 | Disproportionality analysis of adverse neurological and psychiatric reactions with the ChAdOx1 (Oxford-AstraZeneca) and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines in the United Kingdom. | Expert Opinion on Drug Safety | 2023 |
| 36096430 | Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55.2-adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-controlled trial. | Clinical Microbiology and Infection | 2023 |
| 37659896 | Developmental and reproductive safety of Advax-CpG55.2â¿¢ adjuvanted COVID-19 and influenza vaccines in mice. | | 2023 |
| 37567799 | An Advax-CpG adjuvanted recombinant H5 hemagglutinin vaccine protects mice against lethal influenza infection. | | 2023 |
| 37863669 | Advax-CpG55.2-adjuvanted monovalent or trivalent SARS-CoV-2 recombinant spike protein vaccine protects hamsters against heterologous infection with Beta or Delta variants. | | 2023 |
| 36835602 | Identifying SARS-CoV-2 Drugs Binding to the Spike Fatty Acid Binding Pocket Using In Silico Docking and Molecular Dynamics. | | 2023 |
| 37209651 | Detection, characterization, and persistence of Campylobacter hepaticus, the cause of spotty liver disease in layer hens. | | 2023 |
| 37199229 | Ability of SpikoGen®, an Advax-CpG adjuvanted recombinant spike protein vaccine, to induce cross-neutralising antibodies against SARS-CoV-2 variants. | | 2023 |
| 37258928 | In Silico Structure-Based Vaccine Design. | | 2023 |
| 37355452 | An Advax-CpG55.2â¿¢ adjuvanted recombinant spike protein vaccine protects cynomolgus macaques from a homologous SARS-CoV-2 virus challenge. | Vaccine | 2023 |
| 37532610 | An Advax-CpG55.2 adjuvanted recombinant hemagglutinin vaccine provides immunity against H7N9 influenza in adult and neonatal mice. | | 2023 |
| 37528132 | Author Correction: An intranasal vaccine comprising SARSâ¿¿CoVâ¿¿2 spike receptorâ¿¿binding domain protein entrapped in mannoseâ¿¿conjugated chitosan nanoparticle provides protection in hamsters. | | 2023 |
| 37515028 | Adjuvanted Fusion Protein Vaccine Induces Durable Immunity to in Mice and Non-Human Primates. | | 2023 |
| 35197485 | An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission. | npj Vaccines | 2022 |
| 35456886 | Correction: Stewart et al. Adjuvant Strategies for More Effective Tuberculosis Vaccine Immunity. 2019, , 255. | Microorganisms | 2022 |
| 36224191 | Immunogenicity of MultiTEP platform technology-based Tau vaccine in non-human primates. | npj Vaccines | 2022 |
| 35887049 | Potential COVID-19 Therapies from Computational Repurposing of Drugs and Natural Products against the SARS-CoV-2 Helicase. | International Journal of Molecular Sciences | 2022 |
| 35758850 | Immunogenicity and safety of SpikoGen®, an adjuvanted recombinant SARS-CoV-2 spike protein vaccine as a homologous and heterologous booster vaccination: A randomized placebo-controlled trial. | Immunology | 2022 |
| 35750538 | A typhoid fever protein capsular matrix vaccine candidate formulated with Advax-CpG adjuvant induces a robust and durable anti-typhoid Vi polysaccharide antibody response in mice, rabbits and nonhuman primates. | Vaccine | 2022 |
| 35694694 | Stereoisomeric PamCS based TLR2 agonists: synthesis, structural modelling and activity as vaccine adjuvants. | RSC Medicinal Chemistry | 2022 |
| 35436611 | Safety and immunogenicity of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populations. | Clinical Microbiology and Infection | 2022 |
| 35746469 | Co-Administration of Adjuvanted Recombinant <i>Ov</i>-103 and <i>Ov</i>-RAL-2 Vaccines Confer Protection against Natural Challenge in A Bovine <i>Onchocerca ochengi</i> Infection Model of Human Onchocerciasis. | Vaccines (Basel) | 2022 |
| 35630476 | Enhanced Immunogenicity of Inactivated Dengue Vaccines by Novel Polysaccharide-Based Adjuvants in Mice. | Microorganisms | 2022 |
| 35372556 | A Spike Protein-Based Subunit SARS-CoV-2 Vaccine for Pets: Safety, Immunogenicity, and Protective Efficacy in Juvenile Cats. | Frontiers in Veterinary Science | 2022 |
| 35371056 | Evaluation of a Novel Adjuvanted Vaccine for Ultrashort Regimen Therapy of Pollen-Induced Allergic Bronchial Asthma in a Mouse Model. | Frontiers in Immunology | 2022 |
| 36268035 | Prior respiratory syncytial virus infection reduces vaccine-mediated Th2-skewed immunity, but retains enhanced RSV F-specific CD8 T cell responses elicited by a Th1-skewing vaccine formulation. | Frontiers in Immunology | 2022 |
| 35359601 | Computational Repurposing of Drugs and Natural Products Against SARS-CoV-2 Main Protease (M) as Potential COVID-19 Therapies. | Frontiers in Molecular Biosciences | 2022 |
| 35785601 | Toll-like receptor (TLR) agonists as a driving force behind next-generation vaccine adjuvants and cancer therapeutics. | Current Opinion in Chemical Biology | 2022 |
| 36439113 | A recombinant pollen adjuvanted Art v 1 protein-based vaccine treats allergic rhinitis and bronchial asthma using pre- and co-seasonal ultrashort immunotherapy regimens in sensitized mice. | Frontiers in Immunology | 2022 |
| 36411332 | Mucosal immunization with a delta-inulin adjuvanted recombinant spike vaccine elicits lung-resident immune memory and protects mice against SARS-CoV-2. | Mucosal Immunology | 2022 |
| 35465982 | Covax-19/Spikogen® vaccine based on recombinant spike protein extracellular domain with Advax-CpG55.2 adjuvant provides single dose protection against SARS-CoV-2 infection in hamsters. | Vaccine | 2022 |
| 35260593 | A vaccine targeting the L9 epitope of the malaria circumsporozoite protein confers protection from blood-stage infection in a mouse challenge model. | npj Vaccines | 2022 |
| 34915144 | Combined delivery of TLR2 and TLR7 agonists by Nanostructured lipid carriers induces potent vaccine adjuvant activity in mice. | International Journal of Pharmaceutics | 2022 |
| 34914045 | Artificial Intelligence in Vaccine and Drug Design. | Methods in Molecular Biology | 2022 |
| 34362601 | A M2 protein-based universal influenza vaccine containing Advax-SM adjuvant provides newborn protection via maternal or neonatal immunization. | Vaccine | 2021 |
| 33542494 | Intrapulmonary vaccination with delta-inulin adjuvant stimulates non-polarised chemotactic signalling and diverse cellular interaction. | Mucosal Immunology | 2021 |
| 34069575 | Immunogenicity of Adjuvanted Psoralen-Inactivated SARS-CoV-2 Vaccines and SARS-CoV-2 Spike Protein DNA Vaccines in BALB/c Mice. | Pathogens | 2021 |
| 33479242 | An epitope-based malaria vaccine targeting the junctional region of circumsporozoite protein. | npj Vaccines | 2021 |
| 34168168 | In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin. | Scientific Reports | 2021 |
| 33623860 | Strategies for active and passive pediatric RSV immunization. | Therapeutic Advances in Vaccines and Immunotherapy | 2021 |
| 34106786 | Impaired Ca signaling due to hepatic steatosis mediates hepatic insulin resistance in Alström syndrome mice that is reversed by GLP-1 analog treatment. | American Journal of Physiology - Cell Physiology | 2021 |
| 33883559 | Intranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets. | npj Vaccines | 2021 |
| 33940589 | Toll-like receptor-7/8 agonist kill Leishmania amazonensis by acting as pro-oxidant and pro-inflammatory agent. | Journal of Pharmacy and Pharmacology | 2021 |
| 33714652 | Advax adjuvant formulations promote protective immunity against aerosol Mycobacterium tuberculosis in the absence of deleterious inflammation and reactogenicity. | Vaccine | 2021 |
| 33500417 | Onchocerca volvulus bivalent subunit vaccine induces protective immunity in genetically diverse collaborative cross recombinant inbred intercross mice. | NPJ Vaccines | 2021 |
| 34355178 | Structural evolution of toll-like receptor 7/8 agonists from imidazoquinolines to imidazoles. | RSC Medicinal Chemistry | 2021 |
| 33919442 | Advax-CpG Adjuvant Provides Antigen Dose-Sparing and Enhanced Immunogenicity for Inactivated Poliomyelitis Virus Vaccines. | Pathogens | 2021 |
| 32994277 | Relative Adipose Tissue Failure in Alström Syndrome Drives Obesity-Induced Insulin Resistance. | Diabetes | 2021 |
| 33301675 | Developing Translational Vaccines against Heroin and Fentanyl through Investigation of Adjuvants and Stability. | Molecular Pharmaceutics | 2021 |